184 related articles for article (PubMed ID: 1559320)
1. [Carnitine metabolism in chronic kidney failure].
Fiorini F; Patrone E; Castellucci A
Clin Ter; 1992 Jan; 140(1 Pt 2):31-4. PubMed ID: 1559320
[TBL] [Abstract][Full Text] [Related]
2. Dialysis-related carnitine disorder.
Hedayati SS
Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
[TBL] [Abstract][Full Text] [Related]
3. Carnitine replacement in end-stage renal disease and hemodialysis.
Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP
Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
[TBL] [Abstract][Full Text] [Related]
4. Advances in carnitine in chronic uremia.
Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
6. Carnitine metabolism in chronic renal failure. Acute effects of carnitine addition to the dialysate during acetate hemodialysis.
Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A
Contrib Nephrol; 1988; 65():1-23. PubMed ID: 3048873
[No Abstract] [Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. L carnitine in hemodialysis patients.
Calò LA; Vertolli U; Davis PA; Savica V
Hemodial Int; 2012 Jul; 16(3):428-34. PubMed ID: 22360675
[TBL] [Abstract][Full Text] [Related]
9. The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.
Thompson CH; Irish AB; Kemp GJ; Taylor DJ; Radda GK
Clin Nephrol; 1997 Jun; 47(6):372-8. PubMed ID: 9202867
[TBL] [Abstract][Full Text] [Related]
10. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation.
Wanner C; Förstner-Wanner S; Rössle C; Fürst P; Schollmeyer P; Hörl WH
Kidney Int Suppl; 1987 Oct; 22():S132-5. PubMed ID: 3480977
[No Abstract] [Full Text] [Related]
11. Newer aspects of carnitine metabolism in uremia.
Savica V; Calvani M; Benatti P; Santoro D; Monardo P; Mallamace A; Savica R; Bellinghieri G
Semin Nephrol; 2006 Jan; 26(1):52-5. PubMed ID: 16412827
[TBL] [Abstract][Full Text] [Related]
12. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
[TBL] [Abstract][Full Text] [Related]
13. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
[TBL] [Abstract][Full Text] [Related]
14. [Plasma l-carnitine in patients with chronic hemodialysis. II. Pharmacokinetics of l-carnitine and its replacement therapy in these patients].
Kudoh Y; Shoji T; Oimatsu H; Kikuchi K; Imura O; Watarai I
Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):195-202. PubMed ID: 6748336
[No Abstract] [Full Text] [Related]
15. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.
Vaux EC; Taylor DJ; Altmann P; Rajagopalan B; Graham K; Cooper R; Bonomo Y; Styles P
Nephron Clin Pract; 2004; 97(2):c41-8. PubMed ID: 15218329
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of carnitine loss during haemodialysis and haemofiltration.
Rumpf KW; Leschke M; Eisenhauer T; Becker K; Köthe U; Scheler F
Proc Eur Dial Transplant Assoc; 1983; 19():298-301. PubMed ID: 6878244
[TBL] [Abstract][Full Text] [Related]
17. Plasma and muscle carnitine in healthy and hemodialyzed children.
Glöggler A; Bulla M; Puchstein C; Gulotta F; Fürst P
Child Nephrol Urol; 1988-1989; 9(5):277-82. PubMed ID: 3271594
[TBL] [Abstract][Full Text] [Related]
18. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment.
Albertazzi A; Capelli P; Di Paolo B; Pola P; Tondi P; Vaccario O
Proc Eur Dial Transplant Assoc; 1983; 19():302-7. PubMed ID: 6878245
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
[TBL] [Abstract][Full Text] [Related]
20. L-carnitine in dialysed patients: the choice of dosage regimen.
Berard E; Iordache A; Barrillon D; Bayle J
Int J Clin Pharmacol Res; 1995; 15(3):127-33. PubMed ID: 8847154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
